The redundancy of such associations in multiple
tissues and in different clinical subpopulations will further
strengthen the evidence that a particular candidate gene or
gene cluster is important. The fact that intermediate phenotypes
change with age is yet another critical dimension that
must be considered in the design of a strategy to approach the
elusive goal of describing the genotypic basis for essential
hypertension.